{"id":"cd70","name":"CD70","symbol":"CD70","route":"/targets/cd70/","asOf":"2026-09-04","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11937","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125726","uniprot":"https://www.uniprot.org/uniprotkb/P32970/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P32970","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3712913","open-targets":"https://platform.opentargets.org/target/ENSG00000125726","civic":"https://civicdb.org/genes/970/summary","oncokb":"https://www.oncokb.org/gene/CD70","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CD70","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=CD70","depmap":"https://depmap.org/portal/gene/CD70?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000125726-CD70","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/970","omim":"https://www.omim.org/entry/602840"}],"products":[{"id":"adi-270","name":"ADI-270","status":"phase-2","modality":"CAR-T cell therapy","route":"/drugs/adi-270/"},{"id":"cusatuzumab","name":"Cusatuzumab","status":"phase-2","modality":"monoclonal antibody","route":"/drugs/cusatuzumab/"}],"trials":[{"id":"nct04023526","name":"A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy","nct":"NCT04023526","phase":"2","status":"active"},{"id":"nct06480565","name":"A Phase 1/2 Trial of ADI-270 in ccRCC","nct":"NCT06480565","phase":"1/2","status":"active"}],"pathways":[],"companies":["adicet-bio","allogene","oncoverity"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}